Abstract
Hypertension, the leading cause of mortality and the third largest cause of disability, is poorly controlled worldwide. The failure to control hypertension takes an unacceptable toll on patients and their families. In addition to the personal cost, to the individual patient, uncontrolled hypertension creates huge, avoidable economic burdens when viewed in terms of the general population. Almost one-half of patients drop out entirely from treatment within 1 year. This review summarizes key challenges related to hypertension management with special focus on patient compliance. Firstly, we will present consequences of poor blood pressure control. Secondly, methods of patient compliance assessment will be reviewed. Thirdly, we will present recent studies assessing adherence with hypertension treatment. Finally, we will review potential solutions to improve patient compliance and blood pressure control which are of crucial importance for reduction of hypertension-related morbidity and mortality.
Keywords: Hypertension, treatment, compliance, cardiovascular, stroke, ischaemic heart disease, high blood pressure, antihypertensive drugs, Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension), cardiovascular disease, therapeutic inertia, PATIENT COMPLIANCE, antihypertensive drug treat-ment, renin-angiotensin system, white-coat adher-ence, Arterial Hypertension, European Society of Hypertension, European Society of Cardiology, cardiovascular health, Control Hypertension Study
Current Vascular Pharmacology
Title: Improving Patient Compliance with Hypertension Treatment: Mission Possible?
Volume: 8 Issue: 6
Author(s): Marzena Chrostowska and Krzysztof Narkiewicz
Affiliation:
Keywords: Hypertension, treatment, compliance, cardiovascular, stroke, ischaemic heart disease, high blood pressure, antihypertensive drugs, Avoiding Cardiovascular Events in Combination Therapy in Patients Living with Systolic Hypertension), cardiovascular disease, therapeutic inertia, PATIENT COMPLIANCE, antihypertensive drug treat-ment, renin-angiotensin system, white-coat adher-ence, Arterial Hypertension, European Society of Hypertension, European Society of Cardiology, cardiovascular health, Control Hypertension Study
Abstract: Hypertension, the leading cause of mortality and the third largest cause of disability, is poorly controlled worldwide. The failure to control hypertension takes an unacceptable toll on patients and their families. In addition to the personal cost, to the individual patient, uncontrolled hypertension creates huge, avoidable economic burdens when viewed in terms of the general population. Almost one-half of patients drop out entirely from treatment within 1 year. This review summarizes key challenges related to hypertension management with special focus on patient compliance. Firstly, we will present consequences of poor blood pressure control. Secondly, methods of patient compliance assessment will be reviewed. Thirdly, we will present recent studies assessing adherence with hypertension treatment. Finally, we will review potential solutions to improve patient compliance and blood pressure control which are of crucial importance for reduction of hypertension-related morbidity and mortality.
Export Options
About this article
Cite this article as:
Chrostowska Marzena and Narkiewicz Krzysztof, Improving Patient Compliance with Hypertension Treatment: Mission Possible?, Current Vascular Pharmacology 2010; 8 (6) . https://dx.doi.org/10.2174/157016110793563799
DOI https://dx.doi.org/10.2174/157016110793563799 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
ACE2; an ACE up the Sleeve?
Current Enzyme Inhibition The Importance of Reendothelialization After Arterial Injury
Current Pharmaceutical Design Antidiabetic Agents in Patients with Chronic Kidney Disease and End-Stage Renal Disease on Dialysis: Metabolism and Clinical Practice
Current Drug Metabolism Potential Mechanisms of Failure in the Sudden Infant Death Syndrome
Current Pediatric Reviews Targeting Conserved Pathways: Mitochondrial Dysfunction and Beyond
Current Neurovascular Research Adenosine Receptors: New Therapeutic Targets for Inflammation in Diabetic Nephropathy
Inflammation & Allergy - Drug Targets (Discontinued) Ocular Inflammatory Diseases: Molecular Pathogenesis and Immunotherapy
Current Molecular Medicine Design and Development of Novel Azo Prodrugs using Various Permutations and Combinations of 5- and 4-Aminosalicylic Acids for Inflammatory Bowel Disease: A Colon-Targeted Approach
Inflammation & Allergy - Drug Targets (Discontinued) The Developing Role of Neuregulin1 In Cardiac Regenerative Stem Cell Therapy
Current Pharmaceutical Design Genetics of Cholesterol and Lipoprotein Metabolism
Recent Patents on Cardiovascular Drug Discovery Regulation of Angiotensin II Receptor Expression
Current Pharmaceutical Design Development and Characterization Pulsatile Microspheres of Nifedipine for Hypertension
Recent Patents on Drug Delivery & Formulation The Molecular Genetics of Migraine: Toward the Identification of Responsible Genes
Current Genomics Cystic Fibrosis: New Insights into Therapeutic Approaches
Current Respiratory Medicine Reviews Role of WNK Kinases in Blood Pressure Control
Current Hypertension Reviews Targeting Angiogenesis in Thyroid Cancer
Current Angiogenesis (Discontinued) Serum Specific Vasopressin-Degrading Activity is Related to Blood Total Cholesterol Levels in Men but not in Women
Medicinal Chemistry Tobacco Smoking and Association between Betel Nut Chewing and Metabolic Abnormalities Among Military Males: The CHIEF Study
Endocrine, Metabolic & Immune Disorders - Drug Targets Meet Our Editorial Board Member:
Current Drug Safety Changes in Lung Function After Compressed Air Diving
Current Respiratory Medicine Reviews